NeoGenomics, Inc. (NEO) Social Stream
Neogenomics Inc (NEO) Price Targets From Analysts
Use the tables below to see what analysts covering Neogenomics Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-01 | 9 | $60 | $45 | $51.625 | $12.38 | 317% |
| 2021-12-07 | 9 | $60 | $41 | $50.75 | $12.38 | 309.94% |
| 2021-12-17 | 9 | $60 | $41 | $48.5 | $12.38 | 291.76% |
| 2022-01-06 | 9 | $60 | $41 | $49 | $12.38 | 295.8% |
| 2022-01-12 | 9 | $53 | $41 | $47.125 | $12.38 | 280.65% |
| 2022-01-18 | 9 | $53 | $40 | $45.5 | $12.38 | 267.53% |
| 2022-02-01 | 9 | $53 | $40.001 | $45.5 | $12.38 | 267.53% |
| 2022-02-23 | 9 | $53 | $30 | $43.625 | $12.38 | 252.38% |
| 2022-02-24 | 9 | $50 | $24 | $37 | $12.38 | 198.87% |
| 2022-03-01 | 9 | $50 | $24 | $36.25 | $12.38 | 192.81% |
| 2022-03-29 | 9 | $50 | $16 | $30.875 | $12.38 | 149.39% |
| 2022-03-30 | 9 | $29 | $16 | $21.555 | $12.38 | 74.11% |
The Trend in the Analyst Price Target
Over the past 22 months, NEO's average price target has gone down $13.25.
NEO reports an average of 49.98% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-07 | 7 | 65 | 46 | 56.45 | 46.75 | 20.75% |
| 2021-08-28 | 13 | 65 | 50 | 56.80 | 48.49 | 17.14% |
| 2021-09-20 | 13 | 65 | 50 | 56.80 | 47.00 | 20.85% |
| 2021-12-07 | 8 | 60 | 41 | 50.75 | 33.93 | 49.57% |
| 2021-12-17 | 9 | 60 | 41 | 49.00 | 34.11 | 43.65% |
NEO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.89 | 4 | 2 | 3 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
NEO's average broker recommendation rating worsened by 0.56 over the prior 18 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NEO as an investment opportunity.
- Neogenomics Inc's upside potential (average analyst target price relative to current price) is greater than 1319.57% of all US stocks.
- To contextualize these metrics, consider that out of Business Services stocks, Neogenomics Inc's variance in analysts' estimates is lower than -616.51% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, Neogenomics Inc's number of analysts covering the stock is higher than 1073.97% of them.
- Neogenomics Inc's average analyst price target is greater than 549.08% of Business Services stocks.
Stocks similar to Neogenomics Inc in the Business Services industry regarding analyst recommendations and price targets are ZUO, ZETA, and YOU.
Is NEO a Buy, Hold or Sell? See the POWR Ratings now!